Investing Profile

Houman Ashrafian

InvestorVC
Managing Partner at SV Health Investors
Photo of Houman Ashrafian, Managing Partner at SV Health Investors
cb
SV Health Investors Managing Partner
$100K - $5.0M
$1.5M
7
£200M
CompanyStageDateRound SizeTotal Raised
Therini Bio
Series AApr 2023$36M
$62M
Co-investors: Jim Trenkle (Sanofi Ventures), Laurence Barker (SV Health Investors), Mike Ross (SV Health Investors), Pascal Levensohn (Dolby Family Ventures)
Quell Therapeutics
Series BNov 2021$160M
$160M
Mestag Therapeutics
SeedApr 2021$11M
$11M
Alchemab Therapeutics
Series AApr 2021$83M
$83M
Co-investors: Andrew Levin (RA Capital)
Catamaran Bio
Series ANov 2020$42M
$47M
Co-investors: Jack Kenney (SV Health Investors), Maina Bhaman (Soffinova Partners), Caroline Gaynor (Lightstone Ventures)
Enara Bio
Series ANov 2019$18M
$51M
Co-investors: Rana Al-Hallaq (Pfizer Venture Investments)
Sitryx Therapeutics
Series AOct 2018$30M
$30M
Co-investors: Maina Bhaman (Soffinova Partners)